Workflow
Marker Therapeutics to Present at Canaccord Genuity's Horizons in Oncology Conference
MRKRMarker Therapeutics(MRKR) GlobeNewswire News Room·2025-04-01 20:00

Media and Investor Contact To join the virtual panel discussion, please contact your Canaccord Genuity conference representative. About Marker Therapeutics, Inc. Marker Therapeutics, Inc. is a Houston, TX-based clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumors. The Company was founded at Baylor College of Medicine, and clinical trials that enrolled more than 200 patients acro ...